The largest database of trusted experimental protocols

10 protocols using smart system

1

Bis-T-22 Quantification by HPLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bis‐T‐22 and its prodrug derivatives were determined by gradient reverse‐phase HPLC procedure using a Pharmacia Biotech SMART system equipped with a variable wavelength UV detector operated at 254 nm, and a 50μL injection loop. The chromatographic separation was achieved on a GRACEVYDAC C18‐column (5 μm, 100 mm, 2.1 mm) using a H2O (+0.1 % TFA) and CH3CN gradient at a flow rate of 1.0 mL/min. Quantitation of the compounds was done by measuring the peak areas in relation to a benzophenone standard. Data was then analysed using Excel.
+ Open protocol
+ Expand
2

Molecular Mass Determination of 26S Proteasome

Check if the same lab product or an alternative is used in the 5 most similar protocols
Molecular mass of the native 26S proteasome was established by gel filtration chromatography under native conditions on Superose 6 PC 3.2/30 columns (Pharmacia Biotech), connected to a SMART System (Pharmacia Biotech), equilibrated in 25 mM Tris-HCl, pH 7.5 added with 50 mM NaCl, and calibrated with molecular mass standards (26S human proteasome 2100 kDa, 20S human proteasome 700 kDa, apoferritin 443 kDa, porcine Acylpeptide hydrolase 300 kDa, bovine serum albumin 66.5 kDa and chymotrypsin 25 kDa).
+ Open protocol
+ Expand
3

Purification of 26S Proteasome Complex

Check if the same lab product or an alternative is used in the 5 most similar protocols
ATP and glycerol were added to buffers all along the procedure to preserve the interactions between the 20S core and 19S regulatory particles and therefore to maintain 26S proteasome stability [22 (link)]. The 26S proteasome purification was performed as previously reported [18 (link)] with slightly modifications. The active fractions recovered after the chromatography on Phenyl Sepharose column were dialyzed against 25 mM Tris-HCl, pH 7.5 and loaded onto a Superose 6 PC 3.2/30 column (Pharmacia Biotech, Pittsburgh, PA, USA) connected to a SMART System (Pharmacia Biotech). The elution buffer was 25 mM Tris-HCl, pH 7.5 added with 50 mM NaCl and the flow rate was 0.1 mL·min−1. Active fractions were pooled and the purified proteasome was stored in 25 mM Tris-HCl pH 7.5, 1 mM ATP and 10% glycerol.
+ Open protocol
+ Expand
4

Peptide Synthesis, Purification, and Labeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The C-ICD and C-ICDmut peptides were synthesized by Fmoc chemistry using the PSSM-8 automated peptide synthesizer (Shimadzu, Kyoto, Japan) and purified by reverse-phase high-performance liquid chromatography on a C18 column with a linear gradient from 0 to 90 % CH3CN in 0.1 % trifluoroacetic acid for 60 min at a flow rate of 1 ml/min. The purified peptides were digested with trypsin and separated using the Smart System (GE Healthcare, Little Chalfont, UK) on a RP300 column with a linear gradient from 0 to 90 % CH3CN in 0.1 % trifluoroacetic acid for 50 min at a flow rate of 1 ml/min, and the fractions were collected. The individual fractions were analyzed by matrix-assisted laser desorption/ionization time-of-flight collision-induced dissociation tandem mass spectroscopy using the Axima Performance system (Shimadzu), and their amino acid sequences were confirmed by the 492HT protein sequencer (Applied Biosystems, Foster City, CA, USA). FITC-I (Dojindo) was used to label the peptides according to the manufacturer’s instructions. Briefly, the peptide and FITC-I were mixed at a weight ratio of 10:1 in phosphate-buffered saline (PBS) containing 2.5 mM carbonate and were reacted at 4 °C for 4 h. The FITC-labeled peptide was washed with PBS by five centrifugation cycles using an Amicon Ultra-10 K membrane filter (Millipore, Billerica, MA, USA).
+ Open protocol
+ Expand
5

Purification of FLAG-Wnt3a from Conditioned Medium

Check if the same lab product or an alternative is used in the 5 most similar protocols
Five-hundred mL of conditioned medium (C.M.) of FLAG-tagged Wnt3a (FLAG-Wnt3a)-expressing L cells in serum-free condition were prepared. HEPES buffer, pH7.4 (final 10 mM); EDTA, pH8.0 (final 1 mM); and protease inhibitors (final 1 mM PMSF, 5 μg mL−1 leupeptin, 10 μg mL−1  peptstatinA, and 5 μg mL−1 aprotinin) were added to the C.M. Debris was removed by centrifugation for 30 min at 14,000 × g, and the supernatant containing FLAG-Wnt3a was applied to an anti-FLAG M2 affinity gel (Sigma) column that had been equilibrated with 15 mM HEPES buffer, pH7.4-150 mM NaCl. The column was washed with 10 column bed volumes of the same buffer containing 0.1 mM n-Dodecyl-β-D-maltoside. The bound proteins were eluted with the same buffer containing 125 μg mL−1 FLAG peptide (Sigma). The eluate was concentrated 10–30 times with a Microcon centrifuge filter unit YM-100 (Millipore). Further purification was performed by using Superdex200 (PC3.2/30) gel filtration chromatography in a Smart-system (GE Healthcare). The elution of protein was profiled at 280 nm, and the eluate was sub-fractionated into 40-μL fractions.
+ Open protocol
+ Expand
6

Amplifying Biotinylated DNA Fragments

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 500 bp linear dsDNA molecules were amplified from the 3516–4016 region of pBR322 plasmid with biotinylated primers (5’-bGGATCTCAACAGCGGTAA-3’ and 5’ bCTTTATCCGCCTCCATCC-3’). DNA fragments were purified on a MiniQ anion exchange column with a chromatography SMART system (GE Healthcare), ethanol precipitated and resuspended in a 10 mM Tris-HCl, pH 7.5, 1 mM EDTA buffer.
+ Open protocol
+ Expand
7

Gel Filtration Purification of CRCT Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The soluble proteins of the CRCT overexpression line in the crude extract with buffer A (100 μL) were separated by gel filtration chromatography using the SMART system (GE Healthcare) with a Superose 12 PC3.2/30 column equilibrated with buffer A containing 100 mM NaCl.
Separation was performed at a flow rate of 40 μL min -1 . Fractions (40 μL) were collected and subjected to western blot analysis.
+ Open protocol
+ Expand
8

Separation of Soluble Proteins by Gel Filtration

Check if the same lab product or an alternative is used in the 5 most similar protocols
The soluble proteins of the CRCT overexpression line in the crude extract with buffer A (100 µL) were separated by gel filtration chromatography using the SMART system (GE Healthcare) with a Superose 12 PC3.2/30 column equilibrated with buffer A containing 100 mM NaCl. Separation was performed at a flow rate of 40 µL min -1 . Fractions (40 µL) were collected and subjected to western blot analysis.
+ Open protocol
+ Expand
9

Stoichiometry Determination of PDE6-PrBP/δ Complex

Check if the same lab product or an alternative is used in the 5 most similar protocols
For determining the stoichiometry of the complex, PDE6 concentration of ~2 µM with molar ratios of 1, 2 and 3 for PrBP/δ were subjected to gel filtration (50 µl sample volume, Superose 12 column, GE Healthcare, Germany) using SMART systems (GE Healthcare, Germany) in 20 mM BTP (pH 7.5), 130 mM NaCl, 1 mM MgCl2, 1 mM TCEP at 10 °C. The column was previously calibrated using external protein standards (Thyroglobin (669 kDa), Ferritin (440 kDa), Catalase (232 kDa), Alcohol Dehydrogenase (158 kDa), Albumin (67 kDa), Ovalbumin (43 kDa), Chymotrypsine (25 kDa), RNase (13.7 kDa)).
+ Open protocol
+ Expand
10

Purification and Enrichment of PCNA Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following procedures were performed at 4°C using the FPLC and SMART systems (GE Healthcare). Soluble materials from Escherichia coli BL21 (DE3) cells were dissolved in buffer A (20 mM sodium phosphate (pH 7.2), 0.3 M NaCl, 10% glycerol, and 10 mM β-mercaptoethanol), passed through Hitrap DEAE (GE Healthcare), and then loaded onto TALON resin (Clontech). After sequential washes with buffer A and buffer B (20 mM Tris-HCl (pH 8.0), 0.1 M NaCl, 10% glycerol, and 10 mM β-mercaptoethanol), the bound materials were eluted with 0.2 M imidazole in buffer B and loaded onto anti-FLAG M2 agarose. After a wash with buffer B, the bound materials were eluted with buffer B containing 0.1 mg/ml FLAG peptide (Sigma) and then loaded onto anti-HA-agarose (Sigma). After a further wash with buffer B, the bound materials were eluted with buffer B containing 0.1 mg/ml HA peptide (Sigma). The PCNA-enriched fractions detected by SDS-PAGE and Coomassie Brilliant Blue staining were loaded onto a MonoQ/PC1.6/5 column (GE Healthcare) and the proteins were eluted with a linear gradient of NaCl (0.1–0.5 M) in 20 mM sodium phosphate (pH 7.2), 0.1 mM EDTA, 10% glycerol, and 10 mM β-mercaptoethanol.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!